Immunohistology

Documents

CD15

CD15

New CD15 cocktail for enhanced sensitivity for the diagnosis of Hodgkin‘s disease.

Immunohistology: MAX-Line ready-to-use antibodies

Immunohistology: MAX-Line ready-to-use antibodies

Cost-effective antibodies for your routine immunohistochemistry

In the day-to-day routine of the immunohistochemistry laboratory ready-to-use antibodies are often a convenient but expensive alternative to concentrated formats. This isn’t necessary! You are looking for ready-to-use antibodies meeting your demands concerning costs, quality and suitability for routine? With the new MAX-Line Zytomed Systems offers a convenient solution by providing 16 ml ready-to-use and cost-effective antibodies.

Immunohistology: Tenascin C (TNC) – A marker for collagenous colitis

Immunohistology: Tenascin C (TNC) – A marker for collagenous colitis

Tenascin C is an extracellular matrix glyco-protein associated with cell motility, proliferation and differentiation. It is widely expressed during embryogenesis but exhibits a very restricted pattern in adults. It is expressed in the lamina propria and in the basement membrane towards the mucosal surface of normal colon mucosa.

Immunohistology: New markers for lung carcinomas

Immunohistology: New markers for lung carcinomas

Lung cancer is one of the most common cancers worldwide. The many existing subtypes are treated with therapies which differ substantially.

Immunohistology: IVD certified Breast Cancer Panel

Immunohistology: IVD certified Breast Cancer Panel

Breast cancer belongs to the most frequent cancer diseases in women. A reliable immunohistochemical diagnostic is of great importance for the characterisation of the tumour and therefore for the treatment of the patients.

Immunohistology: A new sensitive and specific marker of prostate origin

Immunohistology: A new sensitive and specific marker of prostate origin

The diagnosis of metastatic carcinoma from uncertain primaries or poorly differentiated high-grade neoplasms involving the prostate and adjacent organs can be challenging, especially in the setting of limited cancer foci on a needle biopsy. In practice, the histologic distinction between high-grade prostate cancer and infiltrating high-grade urothelial cancer has significant implications because both tumor entities require different treatments (i.e. hormone therapy for prostate cancer and chemotherapy for urothelial cancer).

Immunhistology: New antibodies for the detection of colon carcinoma

Immunhistology: New antibodies for the detection of colon carcinoma

Colorectal cancer (CRC) is the third most common cancer diagnosed globally, making up 10 % of all cases. Immunohistochemistry is a widely used tool for diagnosis of CRC especially in untypical cases or in cases where the primary tumor is not known (CUP, Cancer of Unknown Primary).